EUCTR2021-001953-30-AT进行中(未招募)1 期
Alternate day dosing compared to consecutive day dosing of oral iron supplements in bariatric patients with iron-deficiency
Verein zur Förderung der Wissenschaft und Forschung an der 1. Med. Abteilung der Klinik Landstraße0 个研究点目标入组 60 人开始时间: 2021年5月27日最近更新:
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中(未招募)
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Age between 18 and 60 years
- •Iron deficiency with hemoglobin level >8mg/dl, that developed in the post-operative period after sleeve gastrectomy or roux-en-Y gastric bypass
- •Ferritin <50µg/dl
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 60
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Preoperative hemoglobin levels <10mg/dl (Anemia of any cause)
- •Preoperative MCV-values over 105 fl
- •Current carcinoma
- •Gastric or duodenal ulcer (within the last three months)
- •Current pregnancy or breast-feeding
- •Copper deficiency
- •Inflammation (CRP > 0,5mg/dl), Acute infections, Chronic inflammatory diseases (f.ex. rheumatoid arthritis)
研究者
相似试验
尚未招募
4 期
Effect of alternate day treatment with teneligliptin in type 2 diabetes mellitus patients.CTRI/2024/06/068564ONE
已完成
2 期
A phase II study of alternate-day administration of S-1, oral leucovorin, oxaliplatin, and bevacizumab combination as first-line treatment in patients with metastatic colorectal cancer.Colorectal cancerJPRN-UMIN000020439Aichi Cancer Center Hospital25
尚未招募
不适用
A Comparative study of different dosing regimens in children with irondeficiency anemiaCTRI/2023/01/048846Amith k
已完成
2 期
Phase II study of alternate-day administrations of S-1 as 1st-line treatment in patients with metastatic and locally advanced pancreatic cancerMetastatic or locally advanced pancreatic cancerJPRN-UMIN000003453Pancreatic Cancer Treatment Research Group45
已完成
2 期
Phase II Study of Alternate-day Administration of S-1 plus Carboplatin in Elderly Patients with Advanced Non-small Cell Lung Canceron-small Cell Lung CancerJPRN-UMIN000012098Tokushukai Group Oncology Project45
